Comparison of eotaxin‐3 biomarker in patients with eosinophilic oesophagitis, proton pump inhibitor‐responsive oesophageal eosinophilia and gastro‐oesophageal reflux disease
Publisher: John Wiley & Sons Inc
E-ISSN: 1365-2036|42|2|231-238
ISSN: 0269-2813
Source: ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.42, Iss.2, 2015-07, pp. : 231-238
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract